I Tried Microdosing with GLP-1
Ben Greenfield — I Tried Microdosing with GLP-1
Channel: Ben Greenfield Life · Our label: Biohacking author & podcaster · Source: youtube.com/watch?v=gB3ESIwLPC0
What this video covers
What do I think about microdosing with GLP-1? I interviewed someone about these Ozempic and GLP-1 agonists and Tirzepatide and megapatide and allopana peptide and all the peptides out there. Starting off, it controlled appetite shockingly well. Meaning, like I would make myself my beautiful, glorious morning blueberry-coconut water smoothie and then just kind of sit there staring at it, asking why the heck I made myself a smoothie.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- What do I think about microdosing with GLP-1?
- I interviewed someone about these Ozempic and GLP-1 agonists and Tirzepatide and megapatide and allopana peptide and all the peptides out there.
- Some users have even reported experiencing pancreatitis and that that’s a life threat, potentially inflammation of the of the pancreas involving severe abdominal pain and nausea and vomiting.
- And so there are other side effects of GLP-1 agonists that have been observed primarily in animal studies, but you know, things like thyroid tumors, cancer.
- 50 micrograms meant that with a full insulin syringe, I was pulling my peptide, my semaglutide, because I was using the peptide version back to the three tick mark.
- And the levels that you would take for a microdose are going to vary from GLP-1 to GLP-1.
Read next
- GLP-1 class — more videos
- Semaglutide — more videos
- Tirzepatide — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.